The CXCR4 Antagonist AMD3100 Has Dual Effects on Survival and Proliferation of Myeloma Cells
Ha-Yon Kim, Ji-Young Hwang, Seong-Woo Kim, Hyo-Jin Lee, Hwan-Jung Yun, Samyong Kim, Deog-Yeon Jo
Cancer Res Treat. 2010;42(4):225-234. Published online 2010 Dec 31 DOI: https://doi.org/10.4143/crt.2010.42.4.225
|
Citations to this article as recorded by
Paradoxical cell targeting of calreticulin-empowered, protein-only nanoparticles
Eloi Parladé, Annabel García-Leon, Eric Voltà-Durán, Ugutz Unzueta, Ramon Mangues, Isolda Casanova, Antonio Villaverde, Esther Vázquez
European Journal of Pharmaceutics and Biopharmaceutics.2024; 202: 114410. CrossRef Lyophilization of biomimetic amyloids preserves their regulatable, endocrine-like functions for nanoparticle release
Marianna TP Favaro, Hèctor López-Laguna, Eric Voltà-Durán, Lorena Alba-Castellon, Julieta M. Sánchez, Isolda Casanova, Ugutz Unzueta, Ramón Mangues, Antonio Villaverde, Esther Vázquez
Applied Materials Today.2024; 39: 102348. CrossRef Time-Prolonged Release of Tumor-Targeted Protein–MMAE Nanoconjugates from Implantable Hybrid Materials
Naroa Serna, Aïda Falgàs, Annabel García-León, Ugutz Unzueta, Yáiza Núñez, Alejandro Sánchez-Chardi, Carlos Martínez-Torró, Ramón Mangues, Esther Vazquez, Isolda Casanova, Antonio Villaverde
Pharmaceutics.2022; 14(1): 192. CrossRef Non-invasive detection and complementary diagnosis of liver metastases via chemokine receptor 4 imaging
Hua Yang, Shanshan Tan, Jingjuan Qiao, Yiting Xu, Zongxiang Gui, Yuguang Meng, Bin Dong, Guangda Peng, Oluwatosin Y. Ibhagui, Weiping Qian, Jimmy Lu, Zezhong Li, Guimin Wang, Jinping Lai, Lily Yang, Hans E. Grossniklaus, Jenny J. Yang
Cancer Gene Therapy.2022; 29(12): 1827. CrossRef Controlling self-assembling and tumor cell-targeting of protein-only nanoparticles through modular protein engineering
Eric Voltà-Durán, Olivia Cano-Garrido, Naroa Serna, Hèctor López-Laguna, Laura Sánchez-García, Mireia Pesarrodona, Alejandro Sánchez-Chardi, Ramón Mangues, Antonio Villaverde, Esther Vázquez, Ugutz Unzueta
Science China Materials.2020; 63(1): 147. CrossRef Engineering Secretory Amyloids for Remote and Highly Selective Destruction of Metastatic Foci
María Virtudes Céspedes, Olivia Cano‐Garrido, Patricia Álamo, Rita Sala, Alberto Gallardo, Naroa Serna, Aïda Falgàs, Eric Voltà‐Durán, Isolda Casanova, Alejandro Sánchez‐Chardi, Hèctor López‐Laguna, Laura Sánchez‐García, Julieta M. Sánchez, Ugutz Unzueta,
Advanced Materials.2020;[Epub] CrossRef Recruiting potent membrane penetrability in tumor cell-targeted protein-only nanoparticles
Naroa Serna, Julieta M Sánchez, Ugutz Unzueta, Laura Sánchez-García, Alejandro Sánchez-Chardi, Ramón Mangues, Esther Vázquez, Antonio Villaverde
Nanotechnology.2019; 30(11): 115101. CrossRef The Involvement of SDF-1α/CXCR4 Axis in Radiation-Induced Acute Injury and Fibrosis of Skin
Jinming Cao, Wei Zhu, Daojiang Yu, Lu Pan, Li Zhong, Yuji Xiao, Yiying Gao, Yang Jiao, Qi Zhang, Jiang Ji, Hongying Yang, Shuyu Zhang, Jianping Cao
Radiation Research.2019; 192(4): 410. CrossRef Chemokine-mimetic plerixafor derivative for tumor-specific delivery of nanomaterials
Seungbeom Ko, Gayong Shim, Jinyoung Kim, Yu-Kyoung Oh
Nano Research.2018; 11(4): 2159. CrossRef Protein Nanoparticles are nontoxic, Tuneable Cell Stressors
Marianna Teixeira de Pinho Favaro, Laura Sánchez-García, Alejandro Sánchez-Chardi, Mónica Roldán, Ugutz Unzueta, Naroa Serna, Olivia Cano-Garrido, Adriano Rodrigues Azzoni, Neus Ferrer-Miralles, Antonio Villaverde, Esther Vázquez
Nanomedicine.2018; 13(3): 255. CrossRef Self-assembling toxin-based nanoparticles as self-delivered antitumoral drugs
Laura Sánchez-García, Naroa Serna, Patricia Álamo, Rita Sala, María Virtudes Céspedes, Mònica Roldan, Alejandro Sánchez-Chardi, Ugutz Unzueta, Isolda Casanova, Ramón Mangues, Esther Vázquez, Antonio Villaverde
Journal of Controlled Release.2018; 274: 81. CrossRef The CXCR4 antagonist plerixafor (AMD3100) promotes proliferation of Ewing sarcoma cell lines in vitro and activates receptor tyrosine kinase signaling
Philipp Berning, Christiane Schaefer, Dagmar Clemens, Eberhard Korsching, Uta Dirksen, Jenny Potratz
Cell Communication and Signaling.2018;[Epub] CrossRef Switching cell penetrating and CXCR4-binding activities of nanoscale-organized arginine-rich peptides
Marianna Teixeira de Pinho Favaro, Naroa Serna, Laura Sánchez-García, Rafael Cubarsi, Mónica Roldán, Alejandro Sánchez-Chardi, Ugutz Unzueta, Ramón Mangues, Neus Ferrer-Miralles, Adriano Rodrigues Azzoni, Esther Vázquez, Antonio Villaverde
Nanomedicine: Nanotechnology, Biology and Medicine.2018; 14(6): 1777. CrossRef The inhibitory effects and mechanisms of 3,6-O-sulfated chitosan against human papillomavirus infection
Yanyun Gao, Wei Liu, Wei Wang, Xiaoshuang Zhang, Xia Zhao
Carbohydrate Polymers.2018; 198: 329. CrossRef CXCL12/CXCR4/CXCR7 Chemokine Axis in the Central Nervous System: Therapeutic Targets for Remyelination in Demyelinating Diseases
Tianci Chu, Lisa B. E. Shields, Yi Ping Zhang, Shi-Qing Feng, Christopher B. Shields, Jun Cai
The Neuroscientist.2017; 23(6): 627. CrossRef Hypoxia and hyperoxia differentially control proliferation of rat neural crest stem cells via distinct regulatory pathways of the HIF1α–CXCR4 and TP53–TPM1 proteins
Chien‐Cheng Chen, Ching‐Wu Hsia, Cheng‐Wen Ho, Chang‐Min Liang, Chieh‐Min Chen, Kun‐Lun Huang, Bor‐Hwang Kang, Yi‐Hui Chen
Developmental Dynamics.2017; 246(3): 162. CrossRef CXCL12 and CXCR7 are relevant targets to reverse cell adhesion‐mediated drug resistance in multiple myeloma
Johannes M. Waldschmidt, Anna Simon, Dagmar Wider, Stefan J. Müller, Marie Follo, Gabriele Ihorst, Sarah Decker, Joschka Lorenz, Manik Chatterjee, Abdel K. Azab, Justus Duyster, Ralph Wäsch, Monika Engelhardt
British Journal of Haematology.2017; 179(1): 36. CrossRef CXCR4 blockade with AMD3100 enhances Taxol chemotherapy to limit ovarian cancer cell growth
Patrick M. Reeves, Mojgan A. Abbaslou, Farah R.W. Kools, Mark C. Poznansky
Anti-Cancer Drugs.2017; 28(9): 935. CrossRef AMD3100: A Versatile Platform for CXCR4 Targeting 68Ga-Based Radiopharmaceuticals
Sophie Poty, Eleni Gourni, Pauline Désogère, Frédéric Boschetti, Christine Goze, Helmut R. Maecke, Franck Denat
Bioconjugate Chemistry.2016; 27(3): 752. CrossRef The CXCR4 antagonist plerixafor enhances the effect of rituximab in diffuse large B-cell lymphoma cell lines
Linn Reinholdt, Maria Bach Laursen, Alexander Schmitz, Julie Støve Bødker, Lasse Hjort Jakobsen, Martin Bøgsted, Hans Erik Johnsen, Karen Dybkær
Biomarker Research.2016;[Epub] CrossRef PCAF-mediated Akt1 acetylation enhances the proliferation of human glioblastoma cells
Shuguang Zhang, Guan Sun, Zhimin Wang, Yi Wan, Jun Guo, Lei Shi
Tumor Biology.2015; 36(3): 1455. CrossRef Chemokines and Bone
Annette Gilchrist, Paula H. Stern
Clinical Reviews in Bone and Mineral Metabolism.2015; 13(2): 61. CrossRef AMD3100 reduces CXCR4-mediated survival and metastasis of osteosarcoma by inhibiting JNK and Akt, but not p38 or Erk1/2, pathways in in vitro and mouse experiments
YU-XIN LIAO, ZE-ZE FU, CHENG-HAO ZHOU, LIAN-CHENG SHAN, ZHUO-YING WANG, FEI YIN, LONG-PO ZHENG, YING-QI HUA, ZHENG-DONG CAI
Oncology Reports.2015; 34(1): 33. CrossRef CXC Chemokine Ligand 12 Protects Pancreatic β-Cells from Necrosis through Akt Kinase-Mediated Modulation of Poly(ADP-ribose) Polymerase-1 Activity
Nevena Grdović, Svetlana Dinić, Mirjana Mihailović, Aleksandra Uskoković, Jelena Arambašić Jovanović, Goran Poznanović, Ludwig Wagner, Melita Vidaković, Malka Cohen-Armon
PLoS ONE.2014; 9(7): e101172. CrossRef Potential therapeutic biomarkers in plasma cell myeloma: A flow cytometry study
Wenli Zheng, Dingshen Liu, Xiangshan Fan, Linda Powers, Maitrayee Goswami, Ying Hu, Pei Lin, L. Jeffrey Medeiros, Sa A. Wang
Cytometry Part B: Clinical Cytometry.2013; 84B(4): 222. CrossRef Targeting Paraprotein Biosynthesis for Non-Invasive Characterization of Myeloma Biology
Katharina Lückerath, Constantin Lapa, Annika Spahmann, Gerhard Jörg, Samuel Samnick, Andreas Rosenwald, Herrmann Einsele, Stefan Knop, Andreas K. Buck, Evren Alici
PLoS ONE.2013; 8(12): e84840. CrossRef An Antedrug of the CXCL12 Neutraligand Blocks Experimental Allergic Asthma without Systemic Effect in Mice
François Daubeuf, Muriel Hachet-Haas, Patrick Gizzi, Vincent Gasparik, Dominique Bonnet, Valérie Utard, Marcel Hibert, Nelly Frossard, Jean-Luc Galzi
Journal of Biological Chemistry.2013; 288(17): 11865. CrossRef EETs and CYP2J2 inhibit TNF-α-induced apoptosis in pulmonary artery endothelial cells and TGF-β1-induced migration in pulmonary artery smooth muscle cells
WENJING FENG, XIZHEN XU, GANG ZHAO, GENG LI, TIANTIAN LIU, JUNJIE ZHAO, RUOLAN DONG, DAO WEN WANG, LING TU
International Journal of Molecular Medicine.2013; 32(3): 685. CrossRef The role of the CXCL12-CXCR4/CXCR7 axis in the progression and metastasis of bone sarcomas (Review)
YU-XIN LIAO, CHENG-HAO ZHOU, HUI ZENG, DONG-QING ZUO, ZHUO-YING WANG, FEI YIN, YING-QING HUA, ZHENG-DONG CAI
International Journal of Molecular Medicine.2013; 32(6): 1239. CrossRef Why and how to find neutraligands targeting chemokines?
Jean-Luc Galzi, Muriel Haas, Nelly Frossard, Marcel Hibert
Drug Discovery Today: Technologies.2012; 9(4): e245. CrossRef Sublytic C5b‐9 complexes induce proliferative changes of glomerular mesangial cells in rat Thy‐1 nephritis through TRAF6‐mediated PI3K‐dependent Akt1 activation
Wen Qiu, Yan Zhang, Xiaomei Liu, Jianbo Zhou, Yan Li, Ying Zhou, Kai Shan, Mei Xia, Nan Che, Xuefeng Feng, Dan Zhao, Yingwei Wang
The Journal of Pathology.2012; 226(4): 619. CrossRef Initial Assessment of the Role of CXC Chemokine Receptor 4 after Polytrauma
Harold H. Bach, Vikas Saini, Todd A. Baker, Abhishek Tripathi, Richard L. Gamelli, Matthias Majetschak
Molecular Medicine.2012; 18(7): 1056. CrossRef Differential effects of CXCR4 antagonists on the survival and proliferation of myeloid leukemia cellsin vitro
Ha-Yon Kim, Ji-Young Hwang, Yoon-Suk Oh, Seong-Woo Kim, Hyo-Jin Lee, Hwan-Jung Yun, Samyong Kim, Young-Jun Yang, Deog-Yeon Jo
The Korean Journal of Hematology.2011; 46(4): 244. CrossRef
|